Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?

Moliva JI, Turner J, Torrelles JB.

Front Immunol. 2017 Apr 5;8:407. doi: 10.3389/fimmu.2017.00407. eCollection 2017. Review.

2.
3.

A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.

Bellmunt J, Powles T, Vogelzang NJ.

Cancer Treat Rev. 2017 Mar;54:58-67. doi: 10.1016/j.ctrv.2017.01.007. Epub 2017 Feb 2. Review.

4.

Nanotechnology-Based Approach in Tuberculosis Treatment.

Nasiruddin M, Neyaz MK, Das S.

Tuberc Res Treat. 2017;2017:4920209. doi: 10.1155/2017/4920209. Epub 2017 Jan 22. Review.

5.

Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection.

Warren E, Teskey G, Venketaraman V.

J Clin Med. 2017 Feb 7;6(2). pii: E15. doi: 10.3390/jcm6020015. Review.

6.

Experimental animal modelling for TB vaccine development.

Cardona PJ, Williams A.

Int J Infect Dis. 2017 Mar;56:268-273. doi: 10.1016/j.ijid.2017.01.030. Epub 2017 Feb 3. Review.

7.

Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model.

Rao M, Cadieux N, Fitzpatrick M, Reed S, Arsenian S, Valentini D, Parida S, Dodoo E, Zumla A, Maeurer M.

Int J Infect Dis. 2017 Mar;56:274-282. doi: 10.1016/j.ijid.2017.01.024. Epub 2017 Feb 2. Review.

8.

Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination.

Valentini D, Rao M, Rane L, Rahman S, Axelsson-Robertson R, Heuchel R, Löhr M, Hoft D, Brighenti S, Zumla A, Maeurer M.

Int J Infect Dis. 2017 Mar;56:140-154. doi: 10.1016/j.ijid.2017.01.027. Epub 2017 Feb 2. Review.

9.

Novel approaches to tuberculosis vaccine development.

Kaufmann SH, Weiner J, von Reyn CF.

Int J Infect Dis. 2017 Mar;56:263-267. doi: 10.1016/j.ijid.2016.10.018. Epub 2016 Nov 2. Review.

10.

Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.

Higgins JP, Soares-Weiser K, López-López JA, Kakourou A, Chaplin K, Christensen H, Martin NK, Sterne JA, Reingold AL.

BMJ. 2016 Oct 13;355:i5170. doi: 10.1136/bmj.i5170. Review.

11.

Non-specific immunological effects of selected routine childhood immunisations: systematic review.

Kandasamy R, Voysey M, McQuaid F, de Nie K, Ryan R, Orr O, Uhlig U, Sande C, O'Connor D, Pollard AJ.

BMJ. 2016 Oct 13;355:i5225. doi: 10.1136/bmj.i5225. Review.

12.

Immunobiology and immunotherapy in genitourinary malignancies.

Tsiatas M, Grivas P.

Ann Transl Med. 2016 Jul;4(14):270. doi: 10.21037/atm.2016.06.29. Review.

13.

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy.

Tanner R, O'Shea MK, Fletcher HA, McShane H.

Vaccine. 2016 Sep 7;34(39):4656-65. doi: 10.1016/j.vaccine.2016.07.058. Epub 2016 Aug 12. Review.

14.

Revaccination with Live Attenuated Vaccines Confer Additional Beneficial Nonspecific Effects on Overall Survival: A Review.

Benn CS, Fisker AB, Whittle HC, Aaby P.

EBioMedicine. 2016 Aug;10:312-7. doi: 10.1016/j.ebiom.2016.07.016. Epub 2016 Jul 15. Review.

15.

High-Risk Non-Muscle-Invasive Bladder Cancer-Therapy Options During Intravesical BCG Shortage.

Veeratterapillay R, Heer R, Johnson MI, Persad R, Bach C.

Curr Urol Rep. 2016 Sep;17(9):68. doi: 10.1007/s11934-016-0625-z. Review.

16.

Leprosy among children under 15 years of age: literature review.

Oliveira MB, Diniz LM.

An Bras Dermatol. 2016 Apr;91(2):196-203. doi: 10.1590/abd1806-4841.20163661. Review.

17.

Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Duthie MS, Balagon MF.

Risk Manag Healthc Policy. 2016 Apr 27;9:43-53. doi: 10.2147/RMHP.S76058. eCollection 2016. Review.

18.

Harnessing the beneficial heterologous effects of vaccination.

Goodridge HS, Ahmed SS, Curtis N, Kollmann TR, Levy O, Netea MG, Pollard AJ, van Crevel R, Wilson CB.

Nat Rev Immunol. 2016 Jun;16(6):392-400. doi: 10.1038/nri.2016.43. Epub 2016 May 9. Review.

19.

TB vaccine development and the End TB Strategy: importance and current status.

Fletcher HA, Schrager L.

Trans R Soc Trop Med Hyg. 2016 Apr;110(4):212-8. doi: 10.1093/trstmh/trw016. Review.

20.

Developments in Intralesional Therapy for Metastatic Melanoma.

Sloot S, Rashid OM, Sarnaik AA, Zager JS.

Cancer Control. 2016 Jan;23(1):12-20. Review.

Supplemental Content

Loading ...
Support Center